TSK OptiXion
Ophthalmic Needle. 510(k) K262516, from Tsk Laboratory, Japan (Tochigi-Ken, JP). Product code QYM, class 2.
As of Nov 21, 2026, K262516 is an FDA 510(k) held by Tsk Laboratory, Japan, substantially equivalent on Oct 6, 2026 after 77 days, with no recalls tied to it in FDA's recall database.
- Review time: 77 days
- Recalls: 0
The TSK OptiXion needle is indicated for subcutaneous or intravitreal injection and withdrawal of fluids. It is intended for use with a Luer-tip syringe.
- LDS Needle; OcuSafe® LDS Needle; SteriCap® LDS Safety Needle; VitreJect® LDS Safety NeedleK242956 · Ocuject, LLC · Oct 25, 2024
- STERiJECT Ophthalmic Needle; STERiJECT Ophthalmic Needle Low Dead Space (LDS)K242073 · Tsk Laboratory International Japan KK · Oct 23, 2024
- Terumo Injection Filter Needle (NF-3013RBKE05M)K230951 · Terumo Europe N.V. · Oct 18, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 21, 2026
- Review panel
- General Hospital
- Regulation
- 21 CFR 880.5570
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files